Keyphrases
Transcription Inhibitors
100%
In Silico Screening
100%
Bacterial Gene Expression
100%
Structure-based Drug Design
100%
RNA Polymerase Holoenzyme
100%
Bacterial RNA Polymerase
66%
Microscopy
33%
Bacillus Subtilis (B. subtilis)
33%
Growth Inhibition
33%
Binding Site
33%
Cell Activity
33%
Living Cells
33%
In Vitro Assay
33%
RNA Polymerase II (RNAPII)
33%
Excellent Activity
33%
Publicly Available
33%
Inhibitor Development
33%
Virtual Screening
33%
Pharmacophore Model
33%
Discovery Process
33%
Target Specificity
33%
Holoenzyme
33%
Biochemical Verification
33%
Equivalent Structure
33%
Gram-positive Organisms
33%
Specific Affinity
33%
Natural Extracts
33%
RNA Polymerase Activity
33%
Targeted Inhibitors
33%
Antibacterial Activity
33%
Medicine and Dentistry
In Silico
100%
RNA Polymerase
100%
Holoenzyme
100%
Bacterial RNA
50%
In Vitro
25%
Antiinfective Agent
25%
Pharmacophore
25%
Growth Inhibition
25%
Cell Activity
25%
Virtual Screening
25%
Bacillus subtilis
25%
Antibacterial Activity
25%
Binding Site
25%
Gram-Positive Bacteria
25%
RNA Polymerase II
25%
Pharmacology, Toxicology and Pharmaceutical Science
Drug Development
100%
Holoenzyme
100%
RNA Polymerase
100%
Bacterial RNA
50%
Gram Positive Bacterium
25%
Antibacterial Activity
25%
Virtual Screening
25%
Antiinfective Agent
25%
Binding Site
25%
RNA Polymerase II
25%
Biochemistry, Genetics and Molecular Biology
Bacterial Transcription
100%
RNA Polymerase
100%
Transcription
25%
Antibacterial Activity
25%
Extract
25%
Pharmacophore
25%
Cell Activity
25%
Binding Site
25%
Gram Positive Bacterium
25%
Growth Inhibition
25%
RNA Polymerase II
25%